Chlorthalidone no better than hydrochlorothiazide for HTN

March 20, 2013

Chlorthalidone no better than hydrochlorothiazide for HTN
For older adults with hypertension, chlorthalidone is not associated with fewer adverse cardiovascular events or death, but correlates with increased hypokalemia compared with hydrochlorothiazide, according to a study published in the March 19 issue of the Annals of Internal Medicine.
(HealthDay)—For older adults with hypertension, chlorthalidone is not associated with fewer adverse cardiovascular events or death, but correlates with increased hypokalemia compared with hydrochlorothiazide, according to a study published in the March 19 issue of the Annals of Internal Medicine.

Irfan A. Dhalla, M.D., from St. Michael's Hospital in Toronto, and colleagues conducted an observational cohort study involving 29,873 individuals aged 66 years or older who were newly treated with chlorthalidone or hydrochlorothiazide and were not hospitalized for , stroke, or myocardial infarction in the prior year. Chlorthalidone recipients (10,384 patients) were matched with up to two hydrochlorothiazide recipients based on age, sex, year of treatment initiation, and .

During up to five years of follow-up, the researchers found that the rate of a composite of death or hospitalization for heart failure, stroke, or was not significantly different between the groups (3.2 events per 100 person-years of follow-up among chlorthalidone recipients versus 3.4 events for hydrochlorothiazide recipients). Hospitalization with hypokalemia (adjusted hazard ratio, 3.06) or hyponatremia (adjusted hazard ratio, 1.68) was significantly more likely in patients treated with chlorthalidone. In post-hoc analyses, hospitalization with hypokalemia was more likely with chlorthalidone in all dose comparisons between the two drugs (12.5, 25, or 50 mg daily) in which a significant association was found.

"In the absence of convincing evidence for the superiority of either chlorthalidone or hydrochlorothiazide, we believe that clinicians who care for older adults should focus primarily on reaching patient-relevant blood pressure goals while being mindful of the risk for electrolyte abnormalities in patients treated with diuretics," write the authors.

One author disclosed to pharmaceutical companies.

Explore further: Sulfonylureas up cardio events versus metformin

More information: Full Text (subscription or payment may be required)

Related Stories

Sulfonylureas up cardio events versus metformin

November 7, 2012
(HealthDay)—Use of sulfonylureas for initial treatment of diabetes is associated with increased cardiovascular events and death compared with metformin, according to a study published in the Nov. 6 issue of the Annals of ...

Choice of psoriasis treatment affects CVD event rates

September 27, 2012
(HealthDay)—Compared with other anti-psoriatic therapies, systemic anti-inflammatory treatment of patients with severe psoriasis with biologic agents or methotrexate is associated with a lower combined risk of death, myocardial ...

Metformin cuts cardio events in high-risk type 2 diabetes

January 8, 2013
(HealthDay)—Metformin therapy significantly reduces cardiovascular events in high-risk patients with type 2 diabetes compared to treatment with glipizide, according to a study published online Dec. 10 in Diabetes Care.

Clopidogrel after MI less effective in diabetes patients

September 5, 2012
(HealthDay)—Clopidogrel therapy following a heart attack does less to reduce the risk of death in patients with diabetes than in those without diabetes, according to a study published in the Sept. 5 issue of the Journal ...

Combo of diabetes, depression increases post-MI mortality

February 27, 2012
(HealthDay) -- Having both diabetes and depression significantly increases the risk of dying in the years following a heart attack, beyond the increased risk from either condition alone, according to a study published in ...

Recommended for you

Can stem cells help a diseased heart heal itself? Researchers achieve important milestone

December 14, 2018
A team of Rutgers scientists, including Leonard Lee and Shaohua Li, have taken an important step toward the goal of making diseased hearts heal themselves—a new model that would reduce the need for bypass surgery, heart ...

Higher risk of heart attack on Christmas Eve

December 12, 2018
The risk of heart attack peaks at around 10pm on Christmas Eve, particularly for older and sicker people, most likely due to heightened emotional stress, finds a Swedish study in this week's Christmas issue of The BMJ.

Your weight history may predict your heart failure risk

December 12, 2018
In a medical records analysis of information gathered on more than 6,000 people, Johns Hopkins Medicine researchers conclude that simply asking older adult patients about their weight history at ages 20 and 40 could provide ...

Age is the biggest risk for heart disease, but lifestyle and meds have impact

December 12, 2018
Of all the risk factors for heart disease, age is the strongest predictor of potential trouble.

New understanding of mysterious 'hereditary swelling'

December 12, 2018
For the first time ever, biomedical researchers from Aarhus University, Denmark, report cellular defects that lead to a rare disease, hereditary angioedema (HAE), in which patients experience recurrent episodes of swelling ...

Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes

December 11, 2018
Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.